EIR Momenta Pharmaceuticals Jun 2012

Paraluman Leonin FDA, Kenneth Williams FDA$595.00 - Available Now

FDA investigators audited the Momenta Pharmaceuticals - Cambridge, MA, United States facility and issued inspectional observation (via FDA 483) on 08 Jun 2012.

Product details

  • Category:
  • Inspection end: 08 Jun 2012
  • Location: Cambridge, United States
  • FEI: 3005948218
Add To Cart